6 Sites on 18 SubjectsOncology Novel Biologic PHASE III
BETH TRIAL: Multicenter interventional trial of adyuvant therapy for HER2+Node-Positive or high risks Node-Negative Breast Cancer. Roche 2008
Start-up
Regulatory Affairs
3 Sites on 60 SubjectsOncologyPHASE III
Zolendronic Acid in prostatic cancer. CIBA-GEIGY 1997-1999
Start-up
Regulatory Affairs
Clinical Operations
3 Sites on 60 SubjectsOncologyPHASE III
Zolendronic Acid in multiple myeloma. CIBA-GEIGY 1992-1995
Start-up
Regulatory Affairs
Clinical Operations
3 sites and 75 subjectsOncologyPhase III
Zolendronic Acid in breast cancer. CIBA-GEIGY 1989-1992
Start-up
Regulatory Affairs
Clinical Operations
10 Sites on 300 SubjectsCardiovascularPHASE III
Valsartan. Phase III Triasl to assess the efficacy and safety of valsartan alone and in combination with hydroclorothiazide with or amlodipine for aterial hypertension control. NOVARTIS 2005-2008
Start-up
Regulatory Affairs
Clinical Operations
2 Sites and 60 subjectsOncologyPHASE III
Pamidronate in prostatic cancer. CIBA-GEIGY 1986-1988